D'Liver

D’Liver will present their Liverpass development at the investor arrangement InventIT today organized by Norinnova Technology Transfer AS and KUPA.

Yesterday, we had a very interesting meeting with Oslo Cancer Cluster Incubator at Norinnova Technology Transfer AS . Afterwards OCC Incubator's representatives visited our laboratory at BB Lab.

We are proud to announce that we have two new papers published in International Journal of Pharmaceutics together with our partner, AstraZeneca. You can find the references here: http://dliver.com/publications-1

Publications | D'Liver Sørensen, KK; McCourt, PA; Berg, T; Crossley, C; LeCouteur, D; Wake, K; Smedsrød, B. The scavenger endothelial cell - a new player in homeostasis and immunity. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 2012; 303: R1217 - 30.

We are currently updating our website and other digital platforms to reflect our current product and services. Check out www.dliver.com to view our new content.

D'Liver D’Liver provides tailored in vivo liver uptake studies of biologics and nanopharmaceuticals, as well as general pharmacokinetic, biodistribution and liver cell toxicology assays.

D'Liver at Eurotox 2014 in Edinborough

Vi har fått litt stæsj.

D'Liver skal på konferanse i september og har fått laget roll up. Vi synes den er kjempefin.